Cargando…
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression
From the first reported role of the transcription factor RUNX2 in osteoblast and chondrocyte differentiation and migration to its involvement in promigratory/proinvasive behavior of breast, prostate, and thyroid cancer cells, osteosarcoma, or melanoma cells, RUNX2 currently emerges as a key player i...
Autores principales: | Cohen-Solal, Karine A., Boregowda, Rajeev K., Lasfar, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513933/ https://www.ncbi.nlm.nih.gov/pubmed/26204939 http://dx.doi.org/10.1186/s12943-015-0404-3 |
Ejemplares similares
-
The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma
por: Boregowda, Rajeev K., et al.
Publicado: (2016) -
Non-Canonical Smads Phosphorylation Induced by the Glutamate Release Inhibitor, Riluzole, through GSK3 Activation in Melanoma
por: Abushahba, Walid, et al.
Publicado: (2012) -
Interferon Lambda: A New Sword in Cancer Immunotherapy
por: Lasfar, Ahmed, et al.
Publicado: (2011) -
Editorial: Tumor Microenvironment and Resistance to Current Therapies
por: Lasfar, Ahmed, et al.
Publicado: (2019) -
IFN-λ: A New Inducer of Local Immunity against Cancer and Infections
por: Lasfar, Ahmed, et al.
Publicado: (2016)